FDA Adverse Event Malfunction Summary report: N

BINAXNOW STREP PNEUMONIAE 22T (LFR)

MDR report key: 18741246 · Received February 20, 2024

Report

Report Number
1221359-2024-00208
Event Type
Malfunction
Date Received
February 20, 2024
Date of Event
January 25, 2024
Report Date
May 16, 2024
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
GTZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GB
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

D4 UDI: (B)(4). THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 710-100 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 710-000. THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION OR UPON RECEIPT OF NEW INFORMATION.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: B3, B5, B7 D4 UDI: (B)(4) THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 710-100 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 710-000. THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION OR UPON RECEIPT OF NEW INFORMATION. H3 OTHER TEXT : SINGLE USE; DEVICE DISCARDED

Additional Manufacturer Narrative · 0

D4 UDI: (B)(4). DATE OF EVENT PROVIDED IN SECTION B3 IS AN APPROXIMATION, WAS NOT PROVIDED BY CONSUMER. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 710-100 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 710-000. THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION OR UPON RECEIPT OF NEW INFORMATION. H3 OTHER TEXT : SINGLE USE; DEVICE DISCARDED

Additional Manufacturer Narrative · 0

D4 UDI: (B)(4). THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 710-100 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 710-000. TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 236027W WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 710-100 / LOT 236027W, TEST BASE PART NUMBER 710-430R/ LOT 234429. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE AND FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 236027W SHOWED THAT THE COMPLAINT RATE IS (B)(4) RESPECTIVELY. ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE.

Description of Event or Problem · 0

THE CUSTOMER REPORTED CONFLICTING RESULTS WITH THE BINAXNOW STREP PNEUMONIAE PERFORMED ON (B)(6) 2024 ON A URINE SAMPLE. THE CUSTOMER REPORTED THAT THE DIGIVAL WAS READING THE CARD AS POSITIVE WHILE A PERSON WOULD VISUALLY READ THE CARD AS NEGATIVE. REPEAT TESTING WAS PERFORMED WHICH GENERATED A NEGATIVE RESULT. THE CUSTOMER STATED THE PATIENT WAS SYMPTOMATIC. THE CUSTOMER CONFIRMED THERE WAS NO IMPACT IN THE PATIENT'S TREATMENT.

Description of Event or Problem · 0

THE CUSTOMER REPORTED CONFLICTING RESULTS WITH THE BINAXNOW STREP PNEUMONIAE PERFORMED ON (B)(6)2024 ON A KITTED URINE SWAB SAMPLE. THE CUSTOMER REPORTED THAT THE DIGIVAL WAS READING THE CARD AS POSITIVE WHILE A PERSON WOULD VISUALLY READ THE CARD AS NEGATIVE. REPEAT TESTING WAS PERFORMED WHICH GENERATED A NEGATIVE RESULT. THE CUSTOMER STATED THE PATIENT WAS SYMPTOMATIC. THE CUSTOMER CONFIRMED THERE WAS NO IMPACT IN THE PATIENT'S TREATMENT. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED CONFLICTING RESULTS WITH THE BINAXNOW STREP PNEUMONIAE PERFORMED ON AN UNKNOWN DATE ON AN UNKNOWN SAMPLE TYPE. THE CUSTOMER REPORTED THAT THE DIGIVAL WAS READING THE CARD AS POSITIVE WHILE A PERSON WOULD VISUALLY READ THE CARD AS NEGATIVE. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

Description of Event or Problem · 0

THE CUSTOMER REPORTED CONFLICTING RESULTS WITH THE BINAXNOW STREP PNEUMONIAE PERFORMED ON (B)(6) 2024 ON A URINE SAMPLE. THE CUSTOMER REPORTED THAT THE DIGIVAL WAS READING THE CARD AS POSITIVE WHILE A PERSON WOULD VISUALLY READ THE CARD AS NEGATIVE. REPEAT TESTING WAS PERFORMED WHICH GENERATED A NEGATIVE RESULT. THE CUSTOMER STATED THE PATIENT WAS SYMPTOMATIC. THE CUSTOMER CONFIRMED THERE WAS NO IMPACT IN THE PATIENT'S TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1398421 BINAXNOW STREP PNEUMONIAE 22T (LFR) ANTISERA, ALL GROUPS, STREPTOCOCCUS SPP. GTZ ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 236027W

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown